[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9928678D0 - Streptococcus pneumoniae antigens - Google Patents

Streptococcus pneumoniae antigens

Info

Publication number
GB9928678D0
GB9928678D0 GBGB9928678.3A GB9928678A GB9928678D0 GB 9928678 D0 GB9928678 D0 GB 9928678D0 GB 9928678 A GB9928678 A GB 9928678A GB 9928678 D0 GB9928678 D0 GB 9928678D0
Authority
GB
United Kingdom
Prior art keywords
streptococcus pneumoniae
pneumoniae antigens
antigens
streptococcus
pneumoniae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9928678.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Provalis UK Ltd
Original Assignee
Provalis UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provalis UK Ltd filed Critical Provalis UK Ltd
Priority to GBGB9928678.3A priority Critical patent/GB9928678D0/en
Publication of GB9928678D0 publication Critical patent/GB9928678D0/en
Priority to PCT/GB2000/001167 priority patent/WO2000058475A2/en
Priority to CNB200510052830XA priority patent/CN100379758C/en
Priority to EP00912834A priority patent/EP1165795A2/en
Priority to CNB008055890A priority patent/CN1198932C/en
Priority to JP2000608756A priority patent/JP4785014B2/en
Priority to AU15405/01A priority patent/AU1540501A/en
Priority to EP00977771A priority patent/EP1240329A2/en
Priority to JP2001542537A priority patent/JP2003515341A/en
Priority to PCT/GB2000/004602 priority patent/WO2001040472A2/en
Priority to CA002392895A priority patent/CA2392895A1/en
Priority to US09/962,863 priority patent/US20030022181A1/en
Priority to US10/859,548 priority patent/US20040219165A1/en
Priority to US12/559,003 priority patent/US20100143415A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9928678.3A 1999-03-26 1999-12-03 Streptococcus pneumoniae antigens Ceased GB9928678D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB9928678.3A GB9928678D0 (en) 1999-12-03 1999-12-03 Streptococcus pneumoniae antigens
PCT/GB2000/001167 WO2000058475A2 (en) 1999-03-26 2000-03-27 Streptococcus pneumoniae antigens
CNB200510052830XA CN100379758C (en) 1999-03-26 2000-03-27 Streptococcus pneumoniae antigens
EP00912834A EP1165795A2 (en) 1999-03-26 2000-03-27 Streptococcus pneumoniae antigens
CNB008055890A CN1198932C (en) 1999-03-26 2000-03-27 Streptococcus pneumoniae antigens
JP2000608756A JP4785014B2 (en) 1999-03-26 2000-03-27 protein
CA002392895A CA2392895A1 (en) 1999-12-03 2000-12-01 Streptococcus pneumoniae antigens
AU15405/01A AU1540501A (en) 1999-12-03 2000-12-01 Streptococcus pneumoniae antigens
EP00977771A EP1240329A2 (en) 1999-12-03 2000-12-01 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS
JP2001542537A JP2003515341A (en) 1999-12-03 2000-12-01 Streptococcus pneumoniae antigen
PCT/GB2000/004602 WO2001040472A2 (en) 1999-12-03 2000-12-01 Streptococcus pneumoniae antigens
US09/962,863 US20030022181A1 (en) 1999-03-26 2001-09-26 Streptococcus pneumoniae antigens
US10/859,548 US20040219165A1 (en) 1999-03-26 2004-06-03 Streptococcus pneumoniae antigens
US12/559,003 US20100143415A1 (en) 1999-03-26 2009-09-14 Streptococcus Pneumoniae Antigens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9928678.3A GB9928678D0 (en) 1999-12-03 1999-12-03 Streptococcus pneumoniae antigens

Publications (1)

Publication Number Publication Date
GB9928678D0 true GB9928678D0 (en) 2000-02-02

Family

ID=10865707

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9928678.3A Ceased GB9928678D0 (en) 1999-03-26 1999-12-03 Streptococcus pneumoniae antigens

Country Status (6)

Country Link
EP (1) EP1240329A2 (en)
JP (1) JP2003515341A (en)
AU (1) AU1540501A (en)
CA (1) CA2392895A1 (en)
GB (1) GB9928678D0 (en)
WO (1) WO2001040472A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2277897A1 (en) 2001-04-16 2011-01-26 Wyeth Holdings Corporation Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
EP3165531B1 (en) 2010-03-12 2020-11-25 Children's Medical Center Corporation Immunogenic composition, vaccine, and uses thereof
ES2959258T3 (en) 2013-02-07 2024-02-22 Childrens Medical Center Protein antigens that provide protection against pneumococcal colonization and/or disease
EP3849587A4 (en) 2018-09-12 2022-06-29 Affinivax, Inc. Multivalent pneumococcal vaccines
WO2023039223A1 (en) 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474905A (en) * 1993-11-24 1995-12-12 Research Corporation Technologies Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens

Also Published As

Publication number Publication date
WO2001040472A3 (en) 2002-03-14
AU1540501A (en) 2001-06-12
JP2003515341A (en) 2003-05-07
EP1240329A2 (en) 2002-09-18
WO2001040472A2 (en) 2001-06-07
CA2392895A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
HK1043728A1 (en) Vaccine against streptococcus pneumoniae
HUP0301656A3 (en) Streptococcus antigens
HK1118575A1 (en) Streptococcus antigens
AU2002351623A8 (en) Streptococcus antigens
GB0107658D0 (en) Streptococcus pneumoniae
IL162383A0 (en) Streptococcus pneumoniae vaccine
ZA991325B (en) Novel group B streptococcus antigens.
PL346369A1 (en) Streptococcus suis
DE60023158D1 (en) Phagenresistentes streptococcus thermophilus
HUP9801705A2 (en) Streptococcus equi vaccine
GB9928678D0 (en) Streptococcus pneumoniae antigens
AU7193501A (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
IL138958A0 (en) Streptococcus preparation
GB9915419D0 (en) Antigens
GB0026333D0 (en) Streptococcus antigens
GB0028727D0 (en) Streptococcus antigens
EP0898577A4 (en) STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
AU3158200A (en) Haemophilus antigen
AU2003200963A1 (en) Group B Streptococcus Antigens
AUPR135700A0 (en) Haemophilus antigen
GB9912014D0 (en) Antibiotic antibody
GB9822143D0 (en) Antigens
GB0016363D0 (en) Immunisation against chlamydia pneumoniae
GB0017047D0 (en) Immunisation against chlamydia pneumoniae
GB0017983D0 (en) Immunisation against chlamydia pneumoniae

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)